ethinyl estradiol has been researched along with melatonin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Arendt, J; Bojkowski, C; Hanson, S; Labib, MH; Marks, V | 1 |
| Brun, J; Claustrat, B; David, M | 1 |
| Commentz, J; Willig, R | 1 |
| Bazin, R; Bernard, D; Mechkouri, M; Reinberg, AE; Soudant, E; Touitou, Y | 1 |
| Herer, P; Luboshitzky, R; Shen-Orr, Z | 2 |
| Herer, P; Luboshitzky, R; Nave, R; Shen-Orr, Z | 1 |
| Chang, SY; Chen, C; Rodrigues, AD; Yang, Z | 1 |
| Chu, Z; Dai, X; Du, L; Gao, Y; Mu, Y; Qiu, L; Xiong, B; Zhao, B | 1 |
1 trial(s) available for ethinyl estradiol and melatonin
| Article | Year |
|---|---|
Cyproterone acetate-ethinyl estradiol treatment alters urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women.
Topics: Adolescent; Adrenocortical Hyperfunction; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Melatonin | 2002 |
11 other study(ies) available for ethinyl estradiol and melatonin
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Rapid decrease in melatonin production during successful treatment of delayed puberty.
Topics: Adolescent; Ethinyl Estradiol; Female; Humans; Hypogonadism; Melatonin; Puberty, Delayed; Specimen Handling; Time Factors | 1989 |
Urinary melatonin, LH, oestradiol, progesterone excretion during the menstrual cycle or in women taking oral contraceptives.
Topics: Adult; Circadian Rhythm; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Luteinizing Hormone; Melatonin; Menstruation; Norgestrel; Progesterone | 1987 |
No effect of ethinylestradiol treatment on melatonin secretion in healthy pubertal girls.
Topics: Adolescent; Age Determination by Skeleton; Child; Circadian Rhythm; Cross Reactions; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Melatonin; Puberty; Radioimmunoassay | 1995 |
Oral contraceptives alter circadian rhythm parameters of cortisol, melatonin, blood pressure, heart rate, skin blood flow, transepidermal water loss, and skin amino acids of healthy young women.
Topics: Adult; Amino Acids; Analysis of Variance; Biomarkers; Blood Pressure; Body Temperature; Circadian Rhythm; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Heart Rate; Humans; Hydrocortisone; Melatonin; Norethindrone; Norgestrel; Reference Values; Regional Blood Flow; Saliva; Skin; Skin Physiological Phenomena; Water Loss, Insensible | 1996 |
Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women with polycystic ovary syndrome: the effect of ethinyl estradiol-cyproterone acetate treatment.
Topics: Adolescent; Adrenocortical Hyperfunction; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Melatonin; Polycystic Ovary Syndrome | 2003 |
Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
Topics: Adrenal Hyperplasia, Congenital; Adult; Androgen Antagonists; Case-Control Studies; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Melatonin; Polycystic Ovary Syndrome | 2004 |
Further assessment of 17alpha-ethinyl estradiol as an inhibitor of different human cytochrome P450 forms in vitro.
Topics: Aryl Hydrocarbon Hydroxylases; Contraceptives, Oral; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Ethinyl Estradiol; Humans; Hydroxylation; In Vitro Techniques; Intestines; Kinetics; Melatonin; Microsomes, Liver; Oxidoreductases, N-Demethylating; Recombinant Proteins | 2009 |
Melatonin ameliorates the fertilization capacity of oocytes exposed to 17α-ethynylestradiol.
Topics: Animals; Apoptosis; Ethinyl Estradiol; Female; Fertilization; Male; Melatonin; Mice, Inbred ICR; Oocytes; Reactive Oxygen Species; Receptors, Cell Surface; Spermatozoa | 2020 |